Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
99.30
-1.48 (-1.47%)
Oct 6, 2025, 2:28 PM EDT - Market open
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $2.08B in the quarter ending June 30, 2025, with 6.97% growth. This brings the company's revenue in the last twelve months to $7.83B, up 4.11% year-over-year. In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth.
Revenue (ttm)
$7.83B
Revenue Growth
+4.11%
P/S Ratio
2.57
Revenue / Employee
$460,812
Employees
17,000
Market Cap
19.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ZBH News
- 6 hours ago - I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance - Business Wire
- 3 days ago - Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results - PRNewsWire
- 10 days ago - Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System - PRNewsWire
- 27 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 4 weeks ago - Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference - PRNewsWire
- 5 weeks ago - Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care - PRNewsWire
- 5 weeks ago - Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025 - PRNewsWire
- 6 weeks ago - Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference - PRNewsWire